Article

Flagellin synergistically enhances anti-tumor effect of EGFRvIII peptide in a glioblastoma-bearing mouse brain tumor model

2021-11-18

Abstract excerpt

<title>Abstract</title> <p>Purpose Glioblastoma (GBM) is the most aggressive type of brain tumor with heterogeneity and strong invasive ability. Treatment of GBM has not improved significantly despite the progress of immunotherapy and classical therapy. Epidermal growth factor receptor variant III (EGFRvIII), one of GBM-associated mutants, is regarded as an ideal therapeutic target in EGFRvIII-expressed GBM pati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ad8e7316-7327-5dff-a977-6db7b95799b7
DOI: 10.21203/rs.3.rs-1063322/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Flagellin synergistically enhances anti-tumor effect of EGFRvIII peptide in a glioblastoma-bearing mouse brain tumor modelDOI 10.21203/rs.3.rs-1063322/v1Read

The EGFR variant III mutant as a target for immunotherapy of glioblastoma multiforme.Semantic proximity Read

Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomasSemantic proximity Read

Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomasSemantic proximity Read

AI/ML-Assisted Computational Design and Immunoinformatics Evaluation of a Multi-Epitope Vaccine Targeting Podoplanin in <i>Glioblastoma Multiforme</i>Semantic proximity Read

Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITASemantic proximity Read

Systemic delivery of a CXCR4-CXCL12 signaling inhibitor encapsulated in synthetic protein nanoparticles for glioma immunotherapySemantic proximity Read

Anti-VEGF vascular remodeling drives germinal center B cell-rich tertiary lymphoid structures during antibody-toxin and anti-CD40 combination therapy in glioblastomaSemantic proximity Read

Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: A proof of principleSemantic proximity Read

Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts.Semantic proximity Read

Oncolytic Virotherapy in Glioma TumorsSemantic proximity Read

HER2-targeting CAR-T cells show highly efficient anti-tumor activity against glioblastoma both in vitro and in vivoSemantic proximity Read

Humanin activates integrin αV-TGFβ axis and leads to glioblastoma progressionSemantic proximity Read